H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer

Previous studies have indicated that histone methylations act as mediators in the relationship between oestrogen receptor (ER) and breast cancer prognosis, yet the mediating role has never been assessed. Therefore, we investigated seven histone methylations (H3K4me2, H3K4me3, H3K9me1, H3K9me2, H3K9m...

Full description

Bibliographic Details
Main Authors: Cheng-Kun Xiao, Yuexiang Ren, Qianxin Chen, Yuanzhong Yang, Luying Tang, Lin Xu, Zefang Ren
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Epigenetics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/15592294.2024.2343593
_version_ 1826945141411151872
author Cheng-Kun Xiao
Yuexiang Ren
Qianxin Chen
Yuanzhong Yang
Luying Tang
Lin Xu
Zefang Ren
author_facet Cheng-Kun Xiao
Yuexiang Ren
Qianxin Chen
Yuanzhong Yang
Luying Tang
Lin Xu
Zefang Ren
author_sort Cheng-Kun Xiao
collection DOAJ
description Previous studies have indicated that histone methylations act as mediators in the relationship between oestrogen receptor (ER) and breast cancer prognosis, yet the mediating role has never been assessed. Therefore, we investigated seven histone methylations (H3K4me2, H3K4me3, H3K9me1, H3K9me2, H3K9me3, H3K27me3 and H4K20me3) to determine whether they mediate the prognostic impact of ER on breast cancer. Tissue microarrays were constructed from 1045 primary invasive breast tumours, and the expressions of histone methylations were examined by immunohistochemistry. Multifactorial logistic regression was used to analyse the associations between ER and histone methylations. Cox proportional hazard model was performed to assess the relationship between histone methylations and breast cancer prognosis. The mediation effects of histone methylations were evaluated by model-based causal mediation analysis. High expressions of H3K9me1, H3K9me2, H3K4me2, H3K27me3, H4K20me3 were associated with ER positivity, while high expression of H3K9me3 was associated ER negativity. Higher H3K9me2, H3K4me2 and H4K20me3 levels were associated with better prognosis. The association between ER and breast cancer prognosis was most strongly mediated by H4K20me3 (29.07% for OS; 22.42% for PFS), followed by H3K4me2 (11.5% for OS; 10.82% for PFS) and least by H3K9me2 (9.35% for OS; 7.34% for PFS). H4K20me3, H3K4me2 and H3K9me2 mediated the relationship between ER and breast cancer prognosis, which would help to further elucidate the impact of ER on breast cancer prognosis from an epigenetic perspective and provide new ideas for breast cancer treatment.
first_indexed 2024-04-24T07:07:34Z
format Article
id doaj.art-605f46daa4f1474a9baa7030da935d08
institution Directory Open Access Journal
issn 1559-2294
1559-2308
language English
last_indexed 2025-02-17T20:51:11Z
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Epigenetics
spelling doaj.art-605f46daa4f1474a9baa7030da935d082024-12-09T07:21:36ZengTaylor & Francis GroupEpigenetics1559-22941559-23082024-12-0119110.1080/15592294.2024.2343593H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancerCheng-Kun Xiao0Yuexiang Ren1Qianxin Chen2Yuanzhong Yang3Luying Tang4Lin Xu5Zefang Ren6School of Public Health, Sun Yat-sen University, Guangzhou, ChinaSchool of Public Health, Sun Yat-sen University, Guangzhou, ChinaSchool of Public Health, Sun Yat-sen University, Guangzhou, ChinaThe Sun Yat-Sen University Cancer Center, Guangzhou, ChinaThe Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, ChinaSchool of Public Health, Sun Yat-sen University, Guangzhou, ChinaSchool of Public Health, Sun Yat-sen University, Guangzhou, ChinaPrevious studies have indicated that histone methylations act as mediators in the relationship between oestrogen receptor (ER) and breast cancer prognosis, yet the mediating role has never been assessed. Therefore, we investigated seven histone methylations (H3K4me2, H3K4me3, H3K9me1, H3K9me2, H3K9me3, H3K27me3 and H4K20me3) to determine whether they mediate the prognostic impact of ER on breast cancer. Tissue microarrays were constructed from 1045 primary invasive breast tumours, and the expressions of histone methylations were examined by immunohistochemistry. Multifactorial logistic regression was used to analyse the associations between ER and histone methylations. Cox proportional hazard model was performed to assess the relationship between histone methylations and breast cancer prognosis. The mediation effects of histone methylations were evaluated by model-based causal mediation analysis. High expressions of H3K9me1, H3K9me2, H3K4me2, H3K27me3, H4K20me3 were associated with ER positivity, while high expression of H3K9me3 was associated ER negativity. Higher H3K9me2, H3K4me2 and H4K20me3 levels were associated with better prognosis. The association between ER and breast cancer prognosis was most strongly mediated by H4K20me3 (29.07% for OS; 22.42% for PFS), followed by H3K4me2 (11.5% for OS; 10.82% for PFS) and least by H3K9me2 (9.35% for OS; 7.34% for PFS). H4K20me3, H3K4me2 and H3K9me2 mediated the relationship between ER and breast cancer prognosis, which would help to further elucidate the impact of ER on breast cancer prognosis from an epigenetic perspective and provide new ideas for breast cancer treatment.https://www.tandfonline.com/doi/10.1080/15592294.2024.2343593Causal mediation analysisERhistone methylationprognosis
spellingShingle Cheng-Kun Xiao
Yuexiang Ren
Qianxin Chen
Yuanzhong Yang
Luying Tang
Lin Xu
Zefang Ren
H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer
Epigenetics
Causal mediation analysis
ER
histone methylation
prognosis
title H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer
title_full H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer
title_fullStr H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer
title_full_unstemmed H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer
title_short H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer
title_sort h4k20me3 h3k4me2 and h3k9me2 mediate the effect of er on prognosis in breast cancer
topic Causal mediation analysis
ER
histone methylation
prognosis
url https://www.tandfonline.com/doi/10.1080/15592294.2024.2343593
work_keys_str_mv AT chengkunxiao h4k20me3h3k4me2andh3k9me2mediatetheeffectoferonprognosisinbreastcancer
AT yuexiangren h4k20me3h3k4me2andh3k9me2mediatetheeffectoferonprognosisinbreastcancer
AT qianxinchen h4k20me3h3k4me2andh3k9me2mediatetheeffectoferonprognosisinbreastcancer
AT yuanzhongyang h4k20me3h3k4me2andh3k9me2mediatetheeffectoferonprognosisinbreastcancer
AT luyingtang h4k20me3h3k4me2andh3k9me2mediatetheeffectoferonprognosisinbreastcancer
AT linxu h4k20me3h3k4me2andh3k9me2mediatetheeffectoferonprognosisinbreastcancer
AT zefangren h4k20me3h3k4me2andh3k9me2mediatetheeffectoferonprognosisinbreastcancer